Orchestra BioMed
在场
高管
查看带有其 27 名主要高管的组织结构图
Orchestra BioMed 搜索最多的简介
- David Hochman, Chief Executive Officer and Chairman of the Board
- Eric Rose, Director
- Pamela Connealy, Director
高管在Orchestra BioMed变化
- John Mack已作为Director加入公司 (新闻发布的2024七月31号).
- David Pacitti已作为Director加入公司 (新闻发布的2024三月26号).
创建提醒
跟踪 Orchestra BioMed 的高管变动
生物技术
Orchestra BioMed 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Orchestra BioMed 的最新新闻稿
- News Releases | Orchestra BioMed
- Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)
- Biomedical Innovation News & Events | Orchestra BioMed
- Biomedical Innovation News & Events | Orchestra BioMed
- News & Events | Orchestra BioMed
- Clinical Data Presented at ESC Congress Show BackBeat Medical's Cardiac Pacing-Based Treatment for Hypertension Produces Significant, Sustained Reductions in Blood Pressure
- BackBeat Medical Wins Top Honor in TCT 2016 Shark Tank Innovation Competition
- View more press releases Close
通过电子邮件
